Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years

Published:2018-02-20 Issue:5 Volume:265 Page:1016-1025
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Broicher Sarah D.,Filli Linard,Geisseler Olivia,Germann Nicole,Zörner Björn,Brugger P.,Linnebank M.

Funder

Biogen Idec

Swiss MS Society

Betty and David Koetser Foundation

Clinical Research Priority Program

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/article/10.1007/s00415-018-8796-9/fulltext.html

Reference36 articles.

1. Amato MP, Amato MP, Langdon D et al (2012) Treatment of cognitive impairment in multiple sclerosis: position paper. J Neurol 260:1452–1468

2. Benedict RHB, Benedict RHB, Zivadinov R et al (2011) Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 7:332–342

3. Bever CT Jr, Anderson PA, Leslie J et al (1996) Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial. Neurology 47:1457–1462

4. Bobholz JA, Rao SM (2003) Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 16:283–288

5. Braley TJ, Chervin RD (2010) Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment. Sleep 33:1061–1067

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Fatigue Symptoms in the Post-COVID Syndrome With Amifampridine: A Collective Casuistry With Double-Blind Discontinuation Trials;Cureus;2024-01-25

2. Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options – Review Article;Neuropsychiatric Disease and Treatment;2023-11

3. Multimodal agility-based exercise training (MAT) versus strength and endurance training (SET) to improve multiple sclerosis-related fatigue and fatigability during inpatient rehabilitation: a randomized controlled pilot and feasibility study [ReFEx];BMC Neurology;2023-10-28

4. Supramolecular assemblies of cucurbit[n]urils and 4-aminopyridine controlled by cucurbit[n]uril size (n = 5, 6, 7 and 8);Chinese Chemical Letters;2023-07

5. Investigating the safety of Fampridine in patients with different stages of multiple sclerosis;2023-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3